Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. Amazon Location Service.

Clinical trial site

Nationwide Children's Hospital

Nationwide Children's Hospital in Columbus, Ohio, United States is listed as a site for 1,080 registered clinical trials, 340 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,080
Ongoing 340

This page covers the site record Nationwide Children's Hospital in Columbus, Ohio, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Nationwide Children's Hospital, also sponsors trials.

Get the Nationwide Children's Hospital report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,080 trials counted.

  • Phase 1 69 trials
  • Phase 1/2 69 trials
  • Phase 2 185 trials
  • Phase 2/3 26 trials
  • Phase 3 206 trials
  • Phase 4 25 trials
  • Not applicable 218 trials
  • Observational 275 trials
  • Expanded access 7 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 342 trials
  • Completed 598 trials
  • Terminated 110 trials
  • Other 30 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 81

1995: 1 trials (Observational 1) 1996: 1 trials (Observational 1) 1997: 1 trials (Phase 3 1) 1998: 1 trials (Phase 1 1) 1999: 1 trials (Observational 1) 2000: 1 trials (Observational 1) 2001: 2 trials (Phase 3 2) 2002: 2 trials (Observational 1, Phase 3 1) 2003: 5 trials (Observational 2, Phase 3 3) 2004: 11 trials (Observational 3, Not applicable 1, Phase 3 4, Phase 2 3) 2005: 13 trials (Observational 4, Not applicable 2, Phase 3 3, Phase 2 3, Phase 1/2 1) 2006: 16 trials (Observational 3, Not applicable 1, Phase 3 6, Phase 2 4, Phase 1/2 1, Phase 1 1) 2007: 24 trials (Observational 2, Not applicable 3, Phase 4 1, Phase 3 14, Phase 2 3, Phase 1/2 1) 2008: 32 trials (Observational 10, Not applicable 3, Phase 3 5, Phase 2/3 4, Phase 2 7, Phase 1/2 1, Phase 1 2) 2009: 31 trials (Observational 8, Not applicable 4, Phase 3 11, Phase 2 4, Phase 1/2 1, Phase 1 3) 2010: 44 trials (Observational 11, Not applicable 4, Phase 4 4, Phase 3 9, Phase 2/3 2, Phase 2 9, Phase 1/2 1, Phase 1 4) 2011: 38 trials (Observational 13, Not applicable 5, Phase 4 1, Phase 3 7, Phase 2/3 3, Phase 2 6, Phase 1/2 1, Phase 1 2) 2012: 51 trials (Observational 9, Not applicable 12, Phase 4 5, Phase 3 5, Phase 2/3 1, Phase 2 15, Phase 1/2 1, Phase 1 3) 2013: 59 trials (Observational 25, Not applicable 7, Phase 4 2, Phase 3 8, Phase 2/3 1, Phase 2 10, Phase 1/2 3, Phase 1 3) 2014: 56 trials (Observational 20, Not applicable 10, Phase 4 1, Phase 3 11, Phase 2/3 1, Phase 2 7, Phase 1/2 2, Phase 1 4) 2015: 56 trials (Observational 19, Not applicable 9, Phase 4 2, Phase 3 8, Phase 2 11, Phase 1/2 3, Phase 1 4) 2016: 59 trials (Observational 19, Not applicable 12, Phase 4 1, Phase 3 7, Phase 2/3 1, Phase 2 12, Phase 1/2 4, Phase 1 3) 2017: 81 trials (Observational 19, Not applicable 15, Phase 3 17, Phase 2/3 1, Phase 2 16, Phase 1/2 4, Phase 1 9) 2018: 62 trials (Observational 10, Not applicable 16, Phase 4 2, Phase 3 9, Phase 2/3 1, Phase 2 13, Phase 1/2 8, Phase 1 3) 2019: 53 trials (Observational 10, Not applicable 13, Phase 3 9, Phase 2/3 3, Phase 2 11, Phase 1/2 4, Phase 1 3) 2020: 63 trials (Observational 15, Not applicable 16, Phase 3 12, Phase 2 13, Phase 1/2 4, Phase 1 3) 2021: 55 trials (Observational 16, Not applicable 9, Phase 4 2, Phase 3 9, Phase 2/3 1, Phase 2 8, Phase 1/2 7, Phase 1 3) 2022: 63 trials (Observational 10, Not applicable 13, Phase 3 13, Phase 2/3 3, Phase 2 9, Phase 1/2 10, Phase 1 5) 2023: 52 trials (Observational 8, Not applicable 15, Phase 4 3, Phase 3 13, Phase 2/3 4, Phase 2 3, Phase 1/2 1, Phase 1 5) 2024: 56 trials (Observational 14, Not applicable 16, Phase 4 1, Phase 3 7, Phase 2 9, Phase 1/2 6, Phase 1 3) 2025: 40 trials (Observational 10, Not applicable 13, Phase 3 5, Phase 2 6, Phase 1/2 2, Phase 1 4)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 41
2025 40
2024 56
2023 52
2022 63
2021 55
2020 63
2019 53
2018 62
2017 81

2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Conditions studied

The specific conditions of the trials that list this site, most trials first.